Bridgewater Bio Capital

VC / PE

Portfolio talent intelligence

Bridgewater Bio Capital · 5 active portfolio companies · aggregates only, k=5 anonymity

Agents working

Insight Synthesizer·Refreshed capability heatmap across 12 portcos done

Scout·Surfaced 6 new candidates matching standing portco requests running

Negotiator·Drafted intros to 2 candidates for OncoVerse — awaiting approvalapprove

Portfolio companies

Talent coverage score

61+9pp

weighted across capabilities

Critical gaps

AAV CMC scale-up

Diligence packs · Q2

Expert hours · this quarter

1,840

4 standing requests

Capability heatmap (across portfolio)

6mo coverage trend

Phase 2 oncology PIlow gap

coverage: 92%

CMC manufacturing scale-uphigh gap

coverage: 41%

Regulatory CMC / BLAmedium gap

coverage: 55%

AdComm preparationhigh gap

coverage: 28%

Gene-therapy CMC (AAV)critical gap

coverage: 18%

Adaptive trial designlow gap

coverage: 66%

Capability gaps requiring action

AAV CMC scale-up specialist

GeneTrace

high

Matchmaker has 12 candidates queued.

Cell-therapy fill-finish CDMO advisor

Helix Bio

medium

Matchmaker has 7 candidates queued.

RNA delivery (LNP) regulatory CMC

CardioRNA

high

Matchmaker has 5 candidates queued.

Standing requests across portfolio

AAV CMC scale-up specialist

GeneTrace

RNA delivery (LNP) regulatory CMC

CardioRNA

Phase 2 PI · adaptive design

OncoVerse

Translational biomarker advisor

NeuroPath Bio

Salary intelligence

binned for k-anonymity

Fractional CSO (oncology)

US-Northeast

$650–$850/hr

CMC consultant (mRNA)

$450–$600/hr

Phase 2 PI (oncology)

US-Northeast

$500–$700/hr

Recent diligence packs

Acme Therapeutics

Cell therapy · 2 days ago

2 flags

Portfolio companies

OncoVerse

Series B

Immuno-oncology

GeneTrace

Series A

Gene therapy / rare disease

NeuroPath Bio

Series C

CNS / Alzheimer's

Helix Bio

Series B

Cell therapy

CardioRNA

Series A

RNA cardiology

Competitor intel

Frontier Bio Ventures

2 overlap · 7 shared

High overlap on adaptive trial advisors — opportunity for exclusive engagement.

Helix Capital

1 overlap · 3 shared

Recently engaged Dr. Marcus Lin — monitor for COI on shared portfolio.

Recent activity

Insight Synthesizer · refreshed capability heatmap (weekly cadence)
1 hr ago
Scout · discovered 14 new ghost profiles in oncology
today
GeneTrace · approved engagement with Dr. Anika Patel
yesterday
Compliance Sentinel · blocked cross-portco data movement (GDPR mode)
3 days ago